Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein

Oncogenic activation of the PI3K/Akt pathway promotes cellular glucose uptake by downregulating the expression of thioredoxin-interacting protein
复制标题

DOI:
10.1016/j.cellsig.2016.01.011
复制
发表时间:
2016-05-01
影响因子:
4.8
通讯作者:
Hagen, Thilo
Hagen, Thilo
中科院分区:
生物学2区
文献类型:
--
作者:
Hong, Shin Yee;Yu, Fa-Xing;Hagen, Thilo

文献摘要

被引文献

相似文献

已知PI3K/Akt通路的致瘤激活在促进癌细胞的糖代谢中起重要作用。然而,PI3K/Akt信号通路促进癌细胞中葡萄糖利用的分子机制尚不清楚。最近有研究表明,肺腺癌中PI3K/Akt/mTOR信号的致癌激活对于促进葡萄糖转运蛋白1 (GLUT1)在质膜上的定位是重要的。因此,我们假设PI3K/AKT信号的组成性激活对葡萄糖代谢的影响是由硫氧还蛋白相互作用蛋白(TXNIP)介导的,TXNIP是GLUT1质膜定位的已知调节剂。与先前的研究一致,抑制PI3K/Akt通路可降低细胞葡萄糖摄取。此外,临床使用酪氨酸激酶抑制剂(TKIs)抑制非小细胞肺癌(NSCLC)细胞系中PI3K/Akt信号传导可导致GLUT1膜定位减少。我们还观察到,在包括NSCLC细胞在内的各种细胞系中,抑制PI3K/Akt通路导致TXNIP表达增加。重要的是,在NSCLC细胞中使用siRNA敲除TXNIP可促进GLUT1在质膜上定位,并逆转PI3K/Akt抑制剂的作用。总之,我们的研究结果表明,PI3K/Akt信号的致癌激活至少在一定程度上通过调节TXNIP的表达来促进细胞葡萄糖摄取。这一机制可能有助于癌细胞中的Warburg效应。(C) 2016 Elsevier Inc.版权所有。
Oncogenic activation of the PI3K/Akt pathway is known to play an important role to promote glucose metabolism in cancer cells. However, the molecular mechanism through which the PI3K/Akt signalling pathway promotes glucose utilisation in cancer cells is still not well understood. It has recently been shown that the oncogenic activation of the PI3K/Akt/mTOR signalling in lung adenocarcinoma is important in promoting the localisation of glucose transporter 1 (GLUT1) at the plasma membrane. We thus hypothesised that the effect of constitutive activation of the PI3K/AKT signalling on glucose metabolism is mediated by thioredoxin interacting protein (TXNIP), a known regulator of the GLUT1 plasma membrane localisation. Consistent with previous studies, inhibition of the PI3K/Akt pathway decreased cellular glucose uptake. Furthermore, inhibition of PI3K/Akt signalling in non-small cell lung cancer (NSCLC) cell lines using clinically used tyrosine kinase inhibitors (TKIs) resulted in a decrease in GLUT1 membrane localisation. We also observed that inhibition of the PI3K/Akt pathway in various cell lines, including NSCLC cells, resulted in an increase in TXNIP expression. Importantly, knockdown of TXNIP using siRNA in the NSCLC cells promoted GLUT1 to be localised at the plasma membrane and reversed the effect of PI3K/Akt inhibitors. Together, our results suggest that the oncogenic activation of PI3K/Akt signalling promotes cellular glucose uptake, at least in part, through the regulation of TXNIP expression. This mechanism may contribute to the Warburg effect in cancer cells. (C) 2016 Elsevier Inc. All rights reserved.